Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 946 AL 960

Models of LRRK2-Associated Parkinson's Disease

Xiong Y, Dawson TM, Dawson VL.

Adv Neurobiol. 2017;14:163-191. doi: 10.1007/978-3-319-49969-7_9.

Interaction of LRRK2 and α-Synuclein in Parkinson's Disease

Daher JP.

Adv Neurobiol. 2017;14:209-226. doi: 10.1007/978-3-319-49969-7_11.

Small-Molecule Inhibitors of LRRK2

Hatcher JM, Choi HG, Alessi DR, Gray NS.

Adv Neurobiol. 2017;14:241-264. doi: 10.1007/978-3-319-49969-7_13.

Delusional psychosis induced by dopamine agonists in the treatment of Parkinson’s disease: four clinical cases

Bertolín JM, Sáez R, Morant Y.

Actas Esp Psiquiatr. 2017 Mar;45(2):79-88. Epub 2017 Mar 1.

Viral hepatitis and the risk of Parkinson disease

Benito-León J.

Neurology. 2017 Apr 25;88(17):1596-1597. doi: 10.1212/WNL.0000000000003853. Epub 2017 Mar 29.

Disordered voluntary cough as freezing phenomenon in parkinsonism

Ishii M, Mashimo H.

J Phys Ther Sci. 2017 Mar;29(3):558-562. doi: 10.1589/jpts.29.558. Epub 2017 Mar 22.

Recent advances in treating Parkinson's disease

Oertel WH.

F1000Res. 2017 Mar 13;6:260. doi: 10.12688/f1000research.10100.1. eCollection 2017.

Systematic Review and Critical Analysis of Cost Studies Associated with Parkinson's Disease

Bovolenta TM, de Azevedo Silva SM, Arb Saba R, Borges V, Ferraz HB, Felicio AC.

Parkinsons Dis. 2017;2017:3410946. doi: 10.1155/2017/3410946. Epub 2017 Mar 5.

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease

O'Keeffe GW, Hegarty SV, Sullivan AM.

Neuronal Signal. 2017 Mar 31;1(2):NS20170027. doi: 10.1042/NS20170027. eCollection 2017 Apr.

Mitochondrial membrane protein-associated neurodegeneration

Deutschländer A, Konno T, Ross OA.

Parkinsonism Relat Disord. 2017 Jun;39:1-3. doi: 10.1016/j.parkreldis.2017.03.014. Epub 2017 Mar 21.

A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum

Li S, Cheng X, Wang C.

J Ethnopharmacol. 2017 May 5;203:127-162. doi: 10.1016/j.jep.2017.03.049. Epub 2017 Mar 28.

New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases

Xu H, Jiang H, Xie J.

Front Mol Neurosci. 2017 Mar 16;10:71. doi: 10.3389/fnmol.2017.00071. eCollection 2017.

Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts

Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, Masellis M.

Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017.

Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: Implications for chronic neurodegeneration

Glushakova OY, Glushakov AA, Wijesinghe DS, Valadka AB, Hayes RL, Glushakov AV.

Brain Circ. 2017 Apr-Jun;3(2):87-108. doi: 10.4103/bc.bc_27_16. Epub 2017 Jul 18.

Parkinsonism in a patient with valosin-containing protein gene mutation showing: a case report

Fujimaki M, Kanai K, Funabe S, Takanashi M, Yokoyama K, Li Y, Hattori N.

J Neurol. 2017 Jun;264(6):1284-1286. doi: 10.1007/s00415-017-8467-2. Epub 2017 Mar 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias